Literature DB >> 29398678

Evaluation of Two Commercial Enzyme-Linked Immunosorbent Assay Kits for the Detection of Human Circulating Metrnl.

Si-Li Zheng1, Zhi-Yong Li1, Zheng Zhang2, Dong-Sheng Wang1, Jian Xu3, Chao-Yu Miao1.   

Abstract

Metrnl is a newly discovered secreted protein with neurotrophic activity and metabolic effect, while in earlier studies its circulating level in human was not explored. We evaluated two commercial enzyme-linked immunosorbent assay kits (DY7867-05, R&D Systems and SK00478-02, Aviscera Bioscience) for the detection of human circulating Metrnl. The DY7867-05 kit showed superiority over the SK00478-02 kit since it generated better curve fitting degree, smaller variation among tests, higher inter-assay reproducibility and better specificity, and could effectively detect human Metrnl in six types of blood samples. Subsequent analysis was performed using the DY7867-05 kit. Sample storage conditions were investigated. No gender difference in circulating Metrnl levels was found, while people with newly diagnosed type 2 diabetes mellitus (T2DM) had significantly lower Metrnl levels compared to the healthy controls.

Entities:  

Keywords:  blood sample type; circulating Metrnl; enzyme-linked immunosorbent assay (ELISA); gender difference; sample storage; type 2 diabetes mellitus (T2DM)

Mesh:

Substances:

Year:  2018        PMID: 29398678     DOI: 10.1248/cpb.c17-00846

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  Serum Metrnl Level is Correlated with Insulin Resistance, But Not with β-Cell Function in Type 2 Diabetics.

Authors:  Chuan Wang; Youjin Pan; Jia Song; Yu Sun; Hongkai Li; Li Chen; Xinguo Hou
Journal:  Med Sci Monit       Date:  2019-11-25

Review 2.  Role of circulating molecules in age-related cardiovascular and metabolic disorders.

Authors:  Yung Ting Hsiao; Ippei Shimizu; Yohko Yoshida; Tohru Minamino
Journal:  Inflamm Regen       Date:  2022-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.